Although our study focused on tissue-based endocan expression, future investigations may benefit from incorporating noninvasive methods such as serum or plasma endocan measurement using ELISA, which has previously been shown to correlate with tumor progression and prognosis [30]. Here, ESM1 is linked to neoplasm.